1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Pacific Pulmonary Services

Anonymous board for Pacific Pulmonary Services

Sort By:
Title
Replies Views
Last Message ↑
  1. Anonymous
    Replies:
    13
    Views:
    3,183
  2. Anonymous
    Replies:
    4
    Views:
    1,947
  3. Anonymous
    Replies:
    13
    Views:
    2,677
  4. Anonymous
    Replies:
    29
    Views:
    4,166
  5. Anonymous
    Replies:
    78
    Views:
    5,483
  6. Anonymous
    Replies:
    3
    Views:
    1,804
  7. Anonymous
    Replies:
    23
    Views:
    4,065
  8. Anonymous
    Replies:
    30
    Views:
    3,781
  9. Anonymous
    Replies:
    3
    Views:
    1,937
  10. Anonymous
    Replies:
    14
    Views:
    2,968
  11. Anonymous
    Replies:
    12
    Views:
    2,126
  12. Anonymous
    Replies:
    6
    Views:
    2,292
  13. Anonymous
    Replies:
    27
    Views:
    2,480
  14. Anonymous
    Replies:
    0
    Views:
    1,400
  15. Anonymous
    Replies:
    13
    Views:
    7,940
  16. Anonymous
    Replies:
    10
    Views:
    2,622
  17. Anonymous
    Replies:
    8
    Views:
    2,822
  18. Anonymous
    Replies:
    0
    Views:
    1,380
  19. Anonymous
    Replies:
    0
    Views:
    1,311
  20. Anonymous
    Replies:
    0
    Views:
    1,419

Thread Display Options

Loading...